Study of Bavituximab in Patients With Advanced Solid Tumor Malignancies

NCT00129337 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
28
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Peregrine Pharmaceuticals